Alliance Global Partners analyst Jake Sekelsky downgrades Alexco Resource (AMEX:AXU) from Buy to Neutral.
Simulations Plus Enters New Strategic Collaboration To Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
Drug discovery services partnership with Sino-American Cancer Foundation focuses on the development of actionable hits against the MTHFD2 target
Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of modeling